The Chairman of Leadgene Biomedical, along with other recipients of the 22nd Taiwan Golden Root Awards, was received by President Lai Ching-te at the Presidential Office.

 

Committed to anchoring our R&D capabilities in Taiwan while expanding our global presence in biotechnology, Leadgene Biomedical is proud to share that our Chairman, representing the company as a recipient of the 22nd Taiwan Golden Root Awards, was granted an audience with President Lai Ching-te at the Presidential Office on September 22, 2026.

 

During the meeting, President Lai commended the award-winning enterprises for their dedication to technological innovation and their deep commitment to Taiwan. He also emphasized the importance of collaboration between the government and industry in fostering a more resilient and diverse industrial ecosystem.

 

Moving forward, Leadgene Biomedical remains dedicated to advancing biomedical innovation and demonstrating the global competitiveness of Taiwan's biotech sector.

 

 

 

Read the full news release from the Office of the President

 

最終更新：

戻る